MovDisordV3, Main, Exploration, bibRecord, 001182

Caffeine and Risk of Parkinson's Disease in a Large Cohort of Men and Women

Identifieur interne : 001182 ( Main/Exploration ); précédent : 001181; suivant : 001183

Caffeine and Risk of Parkinson's Disease in a Large Cohort of Men and Women

Auteurs : Natalia Palacios [États-Unis] ; XIANG GAO [États-Unis] ; Marjorie L. Mccullough [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Roma Shah [États-Unis] ; Susan Gapstur [États-Unis] ; Alberto Ascherio [États-Unis]

Source :

Movement disorders [ 0885-3185 ] ; 2012.

RBID : Pascal:12-0369632

Descripteurs français

Pascal (Inist)
- Maladie de Parkinson, Pathologie du système nerveux, Caféine, Facteur risque, Homme, Epidémiologie.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Beverages, Caffeine, Caffeine (metabolism), Caffeine (therapeutic use), Central Nervous System Stimulants (therapeutic use), Coffee (metabolism), Cohort Studies, Epidemiology, Female, Human, Humans, Incidence, Male, Nervous system diseases, Nutritional Status, Parkinson Disease (epidemiology), Parkinson Disease (prevention & control), Parkinson disease, Proportional Hazards Models, Questionnaires, Retrospective Studies, Risk Factors, Risk factor, Severity of Illness Index, Sex Characteristics.
MESH :
- chemical , metabolism : Caffeine, Coffee.
- chemical , therapeutic use : Caffeine, Central Nervous System Stimulants.
- epidemiology : Parkinson Disease.
- prevention & control : Parkinson Disease.
- Beverages, Cohort Studies, Female, Humans, Incidence, Male, Nutritional Status, Proportional Hazards Models, Questionnaires, Retrospective Studies, Risk Factors, Severity of Illness Index, Sex Characteristics.

Abstract

Caffeine consumption has been associated with a reduced risk of Parkinson's disease (PD). The association is strong and consistent in men, but uncertain in women, possibly because of an interaction with hormone replacement therapy (HRT). We sought to confirm these findings using data on PD incidence in the Cancer Prevention Study II Nutrition Cohort (CPS II-Nutrition), a large, prospective study of men and women. We conducted a prospective study of caffeine intake and risk of PD within the CPS II Nutrition Cohort. Intakes of coffee and other sources of caffeine were assessed at baseline. Incident cases of PD (n = 317; 197 men and 120 women) were confirmed by treating physicians and medical record review. Relative risks (RRs) were estimated using proportional hazards models, adjusting for age, smoking, and alcohol consumption. After adjustment for age, smoking, and alcohol intake, high caffeine consumption was associated with a reduced risk of PD. The RR comparing the 5th to the 1st quintile of caffeine intake was 0.43 (95% confidence interval [CI]: 0.26, 0.71; P trend = <0.002) in men, and 0.61 (95% CI: 0.34, 1.09; P trend = 0.05) in women. Among women, this association was stronger among never users of HRT (RR = 0.32) than among ever users (RR = 0.81; P interaction = 0.15). Consumption of decaffeinated coffee was not associated with PD risk. Findings from this large, prospective study of men and women are consistent with a protective effect of caffeine intake on PD incidence, with an attenuating influence of HRT in women.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554265

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Caffeine and Risk of Parkinson's Disease in a Large Cohort of Men and Women</title>
<author><name sortKey="Palacios, Natalia" sort="Palacios, Natalia" uniqKey="Palacios N" first="Natalia" last="Palacios">Natalia Palacios</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Xiang Gao" sort="Xiang Gao" uniqKey="Xiang Gao" last="Xiang Gao">XIANG GAO</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="05"><s1>Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mccullough, Marjorie L" sort="Mccullough, Marjorie L" uniqKey="Mccullough M" first="Marjorie L." last="Mccullough">Marjorie L. Mccullough</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Epidemiology Research Program, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schwarzschild, Michael A" sort="Schwarzschild, Michael A" uniqKey="Schwarzschild M" first="Michael A." last="Schwarzschild">Michael A. Schwarzschild</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Neurology, Massachusetts General Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shah, Roma" sort="Shah, Roma" uniqKey="Shah R" first="Roma" last="Shah">Roma Shah</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Epidemiology Research Program, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gapstur, Susan" sort="Gapstur, Susan" uniqKey="Gapstur S" first="Susan" last="Gapstur">Susan Gapstur</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Epidemiology Research Program, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ascherio, Alberto" sort="Ascherio, Alberto" uniqKey="Ascherio A" first="Alberto" last="Ascherio">Alberto Ascherio</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="04"><s1>Department of Epidemiology, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="05"><s1>Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0369632</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0369632 INIST</idno>
<idno type="RBID">Pascal:12-0369632</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000094</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002C20</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000255</idno>
<idno type="wicri:doubleKey">0885-3185:2012:Palacios N:caffeine:and:risk</idno>
<idno type="wicri:Area/Main/Merge">001234</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554265</idno>
<idno type="RBID">PMC:3554265</idno>
<idno type="wicri:Area/Pmc/Corpus">000284</idno>
<idno type="wicri:Area/Pmc/Curation">000284</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000204</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">000C60</idno>
<idno type="wicri:Area/PubMed/Curation">000C60</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F12</idno>
<idno type="wicri:Area/Ncbi/Merge">003786</idno>
<idno type="wicri:Area/Ncbi/Curation">003786</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003786</idno>
<idno type="wicri:doubleKey">0885-3185:2012:Palacios N:caffeine:and:risk</idno>
<idno type="wicri:Area/Main/Merge">000F04</idno>
<idno type="wicri:Area/Main/Curation">001182</idno>
<idno type="wicri:Area/Main/Exploration">001182</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Caffeine and Risk of Parkinson's Disease in a Large Cohort of Men and Women</title>
<author><name sortKey="Palacios, Natalia" sort="Palacios, Natalia" uniqKey="Palacios N" first="Natalia" last="Palacios">Natalia Palacios</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Xiang Gao" sort="Xiang Gao" uniqKey="Xiang Gao" last="Xiang Gao">XIANG GAO</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="05"><s1>Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mccullough, Marjorie L" sort="Mccullough, Marjorie L" uniqKey="Mccullough M" first="Marjorie L." last="Mccullough">Marjorie L. Mccullough</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Epidemiology Research Program, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schwarzschild, Michael A" sort="Schwarzschild, Michael A" uniqKey="Schwarzschild M" first="Michael A." last="Schwarzschild">Michael A. Schwarzschild</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Neurology, Massachusetts General Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shah, Roma" sort="Shah, Roma" uniqKey="Shah R" first="Roma" last="Shah">Roma Shah</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Epidemiology Research Program, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gapstur, Susan" sort="Gapstur, Susan" uniqKey="Gapstur S" first="Susan" last="Gapstur">Susan Gapstur</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Epidemiology Research Program, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ascherio, Alberto" sort="Ascherio, Alberto" uniqKey="Ascherio A" first="Alberto" last="Ascherio">Alberto Ascherio</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="04"><s1>Department of Epidemiology, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="05"><s1>Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Beverages</term>
<term>Caffeine</term>
<term>Caffeine (metabolism)</term>
<term>Caffeine (therapeutic use)</term>
<term>Central Nervous System Stimulants (therapeutic use)</term>
<term>Coffee (metabolism)</term>
<term>Cohort Studies</term>
<term>Epidemiology</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Nervous system diseases</term>
<term>Nutritional Status</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (prevention & control)</term>
<term>Parkinson disease</term>
<term>Proportional Hazards Models</term>
<term>Questionnaires</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Risk factor</term>
<term>Severity of Illness Index</term>
<term>Sex Characteristics</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Caffeine</term>
<term>Coffee</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Caffeine</term>
<term>Central Nervous System Stimulants</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Beverages</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Nutritional Status</term>
<term>Proportional Hazards Models</term>
<term>Questionnaires</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Severity of Illness Index</term>
<term>Sex Characteristics</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du   système nerveux</term>
<term>Caféine</term>
<term>Facteur risque</term>
<term>Homme</term>
<term>Epidémiologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Caffeine consumption has been associated with a reduced risk of Parkinson's disease (PD). The association is strong and consistent in men, but uncertain in women, possibly because of an interaction with hormone replacement therapy (HRT). We sought to confirm these findings using data on PD incidence in the Cancer Prevention Study II Nutrition Cohort (CPS II-Nutrition), a large, prospective study of men and women. We conducted a prospective study of caffeine intake and risk of PD within the CPS II Nutrition Cohort. Intakes of coffee and other sources of caffeine were assessed at baseline. Incident cases of PD (n = 317; 197 men and 120 women) were confirmed by treating physicians and medical record review. Relative risks (RRs) were estimated using proportional hazards models, adjusting for age, smoking, and alcohol consumption. After adjustment for age, smoking, and alcohol intake, high caffeine consumption was associated with a reduced risk of PD. The RR comparing the 5th to the 1st quintile of caffeine intake was 0.43 (95% confidence interval [CI]: 0.26, 0.71; P trend = <0.002) in men, and 0.61 (95% CI: 0.34, 1.09; P trend = 0.05) in women. Among women, this association was stronger among never users of HRT (RR = 0.32) than among ever users (RR = 0.81; P interaction = 0.15). Consumption of decaffeinated coffee was not associated with PD risk. Findings from this large, prospective study of men and women are consistent with a protective effect of caffeine intake on PD incidence, with an attenuating influence of HRT in women.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Géorgie (États-Unis)</li>
<li>Massachusetts</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Palacios, Natalia" sort="Palacios, Natalia" uniqKey="Palacios N" first="Natalia" last="Palacios">Natalia Palacios</name>
</region>
<name sortKey="Ascherio, Alberto" sort="Ascherio, Alberto" uniqKey="Ascherio A" first="Alberto" last="Ascherio">Alberto Ascherio</name>
<name sortKey="Ascherio, Alberto" sort="Ascherio, Alberto" uniqKey="Ascherio A" first="Alberto" last="Ascherio">Alberto Ascherio</name>
<name sortKey="Ascherio, Alberto" sort="Ascherio, Alberto" uniqKey="Ascherio A" first="Alberto" last="Ascherio">Alberto Ascherio</name>
<name sortKey="Gapstur, Susan" sort="Gapstur, Susan" uniqKey="Gapstur S" first="Susan" last="Gapstur">Susan Gapstur</name>
<name sortKey="Mccullough, Marjorie L" sort="Mccullough, Marjorie L" uniqKey="Mccullough M" first="Marjorie L." last="Mccullough">Marjorie L. Mccullough</name>
<name sortKey="Schwarzschild, Michael A" sort="Schwarzschild, Michael A" uniqKey="Schwarzschild M" first="Michael A." last="Schwarzschild">Michael A. Schwarzschild</name>
<name sortKey="Shah, Roma" sort="Shah, Roma" uniqKey="Shah R" first="Roma" last="Shah">Roma Shah</name>
<name sortKey="Xiang Gao" sort="Xiang Gao" uniqKey="Xiang Gao" last="Xiang Gao">XIANG GAO</name>
<name sortKey="Xiang Gao" sort="Xiang Gao" uniqKey="Xiang Gao" last="Xiang Gao">XIANG GAO</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001182 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001182 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:12-0369632
   |texte=   Caffeine and Risk of Parkinson's Disease in a Large Cohort of Men and Women
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Caffeine and Risk of Parkinson's Disease in a Large Cohort of Men and Women

Caffeine and Risk of Parkinson's Disease in a Large Cohort of Men and Women

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.